Remove 2008 Remove Data Remove Sativa Remove Terpenes
article thumbnail

Best strains and terpenes for migraine relief

The Cannigma

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. The study called out pinene, myrcene, and beta-caryophyllene as specifically useful terpenes.

Terpenes 132
article thumbnail

Doctor Block…….”A Physician Botanist’s Insight to Cannabis species: The Naming of Plants and Products”

TheAnswerPage

Cannabis sativa – One plant, Many crops. Because of the challenges in determining geographical origin of modern plants and the possibility for reproduction across the genus, all plants in the genus are most accurately Cannabis sativa. In addition to the THC potency of modern cultivars, one terpene of particular interest is myrcene.

Sativa 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Deal with Memory Loss and Other Negative Effects of Cannabis

Greencamp

When it comes to consuming large quantities of cannabis on a regular basis, available data offers some conflicting conclusions. In a review from 2008, it was emphasized that even after putting a stop to cannabis use, a person’s memory can still remain impaired. ( The effects of cannabis on long-term memory. Get Started.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

The PK data on cats shows there are differences in absorption between cats and dogs and that dosing may be different between these two species and that our chew form is likely to be more absorbable than oils in general. This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45
article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. 2018 ; Frankhauser 2008 ). 2008 )—were difficult for any plant to compete with, especially one whose active constituents would not be revealed for another 30?years Data collection. It also has an extensive and diverse history of medicinal use.